Career history of Phillips N. Dee
Former positions of Phillips N. Dee
| Companies | Position | Start | End |
|---|---|---|---|
RegenoCELL Therapeutics, Inc.
 RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Director/Board Member | 31/01/2002 | 15/07/2008 |
Training of Phillips N. Dee
| The University of North Carolina at Charlotte | Graduate Degree |
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
RegenoCELL Therapeutics, Inc.
RegenoCELL Therapeutics, Inc. BiotechnologyHealth Technology RegenoCELL Therapeutics, Inc. develops a stem-cell therapy business for the treatment of congestive heart failure and peripheral artery disease. It utilizes adult stem cells, derived from the patient's own blood, which eliminates the ethical and safety concerns associated with embryonic and umbilical cord blood stem cells. The stem cell therapy is either delivered through a catheter or injected directly into the myocardium. The company was founded by Scott Massey on February 1, 2002 and is headquartered in Natick, MA. | Health Technology |
- Stock Market
- Insiders
- Phillips N. Dee
- Experience
